[go: up one dir, main page]

AR004378A1 - Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre. - Google Patents

Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre.

Info

Publication number
AR004378A1
AR004378A1 ARP960105644A ARP960105644A AR004378A1 AR 004378 A1 AR004378 A1 AR 004378A1 AR P960105644 A ARP960105644 A AR P960105644A AR P960105644 A ARP960105644 A AR P960105644A AR 004378 A1 AR004378 A1 AR 004378A1
Authority
AR
Argentina
Prior art keywords
emesis
obsessive
dizziness
piperazinyl
aryl
Prior art date
Application number
ARP960105644A
Other languages
English (en)
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of AR004378A1 publication Critical patent/AR004378A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)

Abstract

La invención se refiere a la utilización de derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)-butil}-1H-azol, así como de sus salesfisiológicamente aceptables, para la fabricación de medicamentos destinados al tratamiento de los trastornosobsesivo-compulsivos, la apnea del sueno, lasdisfunciones sexuales, la emesis y al mareo.
ARP960105644A 1995-12-12 1996-12-12 Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre. AR004378A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (fr) 1995-12-12 1995-12-12 Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Publications (1)

Publication Number Publication Date
AR004378A1 true AR004378A1 (es) 1998-11-04

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105644A AR004378A1 (es) 1995-12-12 1996-12-12 Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre.

Country Status (16)

Country Link
EP (1) EP0808166A1 (es)
JP (1) JPH11501051A (es)
CN (1) CN1177297A (es)
AR (1) AR004378A1 (es)
AU (1) AU716665B2 (es)
CA (1) CA2211161A1 (es)
CZ (1) CZ255197A3 (es)
ES (1) ES2134709B1 (es)
FR (1) FR2742052B1 (es)
HU (1) HUP9800198A2 (es)
IL (1) IL121461A0 (es)
NO (1) NO973589L (es)
PL (1) PL321779A1 (es)
TR (1) TR199700794T1 (es)
WO (1) WO1997021439A1 (es)
ZA (1) ZA9610457B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (fr) 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
PT1309593E (pt) 2000-08-14 2006-08-31 Ortho Mcneil Pharm Inc Pirazoles substituidos
ES2262674T3 (es) 2000-08-14 2006-12-01 Ortho-Mcneil Pharmaceutical, Inc. Pirazoles sustituidos.
NZ524193A (en) 2000-08-14 2004-12-24 Ortho Mcneil Pharm Inc Substituted pyrazoles
US6369032B1 (en) 2000-09-06 2002-04-09 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies
CA2580730C (en) 2003-09-25 2015-01-13 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
CA2606473C (en) 2005-04-26 2013-08-13 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (zh) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles

Also Published As

Publication number Publication date
NO973589D0 (no) 1997-08-04
CN1177297A (zh) 1998-03-25
FR2742052B1 (fr) 1998-04-10
MX9706133A (es) 1997-11-29
FR2742052A1 (fr) 1997-06-13
TR199700794T1 (xx) 1997-11-21
JPH11501051A (ja) 1999-01-26
HUP9800198A2 (hu) 1999-09-28
ES2134709B1 (es) 2000-05-16
IL121461A0 (en) 1998-02-08
PL321779A1 (en) 1997-12-22
ES2134709A1 (es) 1999-10-01
CZ255197A3 (cs) 1998-01-14
WO1997021439A1 (fr) 1997-06-19
EP0808166A1 (fr) 1997-11-26
AU716665B2 (en) 2000-03-02
AU1376497A (en) 1997-07-03
NO973589L (no) 1997-10-08
CA2211161A1 (fr) 1997-06-19
ZA9610457B (en) 1997-06-24

Similar Documents

Publication Publication Date Title
AR004378A1 (es) Utilizacion de los derivados de 1-{4-(4-aril(o heteroaril)-1-piperazinil)- butil}-1h-azol para la preparacion de un medicamento destinado al tratamientode los trastornos obsesivo-compulsivos, la apnea del sueno, las disfunciones sexuales, la emesis y el mareo en los mamiferos, incluido el hombre.
BR0312549A (pt) Derivados de indolin-fenilsulfonamida
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
SE0102300D0 (sv) Compounds
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
ES2159209T3 (es) Uso de acido 11-(3-dimetilaminopropiliden)-6,11-dihidrodibenz(b,e)oxepin-2-acetico y de sus sales farmaceuticamente aceptables para la fabricacion de un medicamento para el tratamiento de trastornos oftalmicos no alergicos y para la prevencion de neovascularizacion ocular.
ATE369353T1 (de) Medizinisch verwendbare arylethanolamin verbindungen
MXPA03010810A (es) Pirimidinas inhibidoras de cdk, su obtencion y su uso como medicamentos.
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
EA200601160A1 (ru) 2,6-бисгетероарил-4-аминопиримидины в качестве антагонистов аденозиновых рецепторов
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
UY27092A1 (es) Derivados del novedoso carbamato de quinuclidina y las composiciones medicinales que los contienen
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
AR024847A1 (es) 4-alquenil y 4-alquinil oxindoles, composicion farmaceutica y el uso de los mismos para la fabricacion de un medicamento.
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
DE3688038D1 (de) Verwendung von buspiron zur herstellung von pharmazeutischen zusammensetzungen zur linderung von krankhaften angst.
ATE302774T1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
NO20023362L (no) 1,2-diarylbenzimidazoler for behandling av sykdommer assosiert med en mikrogliaaktivering
DE59904180D1 (de) Cyclopentabenzofuran-derivate und ihre verwendung
ES2089974A1 (es) Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica.
UY27416A1 (es) Uso de bibn4096 en combinación con otros fármacos antimigranosos para el tratamiento de migrana
TR200102008T2 (tr) Serebral işemi profilaksı ve tedavisi için piridin türevlerinin kullanımı.
DK0527081T3 (da) Hidtil ukendte substituerede 3-piperazinylalkyl-2,3-dihydro-1,3-4H-benzoxazin-4-oner, deres fremstilling og terapeutiske anvendelse

Legal Events

Date Code Title Description
FB Suspension of granting procedure